Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism

被引:24
作者
Kovacevic, Bojan [1 ]
Ignjatovic, Mile [1 ]
Zivaljevic, Vladan [2 ]
Cuk, Vladimir [1 ]
Scepanovic, Milena [1 ]
Petrovic, Zaklina [1 ]
Paunovic, Ivan [2 ]
机构
[1] KBC Zvezdara Univ, Ctr Clin, Clin Surg Nikola Spasic, Belgrade 11000, Serbia
[2] Clin Ctr Serbia, Ctr Endocrine Surg, Inst Endocrinol Diabet & Dis Metab, Belgrade 11000, Serbia
关键词
Secondary hyperparathyroidism; NKF-K/DOQI; KDIGO; Parathyroidectomy; Calcimimetics; MORTALITY RISK; MEDICAL THERAPY; BLOOD-PRESSURE; TARGET VALUES; SERUM-CALCIUM; HEMODIALYSIS; CINACALCET; ASSOCIATION; OUTCOMES; HORMONE;
D O I
10.1007/s00423-011-0901-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI (TM)) 2003 and Kidney Disease: Improving Global Outcomes (KDIGO) 2009 have established guidelines for the treatement of secondary hyperparathyroidism. This study evaluated the impact of parathyroidectomy to achieve recommended values for parathyroid hormone, calcium, phosphorus and CaxPO(4) product in dialysis patients with severe secondary hyperparathyroidism that is resistant to medical treatment. This study included 43 consecutive patients who underwent parathyroidectomy for a severe form of secondary hyperparathyroidism (SHPT) that is unresponsive to medical treatment. The serum iPTH, calcium and phosphorus levels were measured prior to surgery, every morning after surgery for 5 days and on the first, sixth and eighth postoperative months. Following parathyroidectomy, a significant decline in iPTH values was observed in all patients; however, after the 8-month study period, only one of these patients achieved a serum iPTH concentration within the K/DOQI recommended target range. Unlike iPTH, targeting for calcium, phosphorus and CaxPO(4) at the last follow-up were 55.8%, 60.5% and 93%, respectively. These values indicated a significant improvement in comparison to preoperative percentages. In regards to the KDIGO recommended guidelines, the iPTH levels did not significantly change at the end of our study compared to preoperative values; however, calcium levels significantly declined and phosphorus levels significantly improved compared to preoperative values. Although the majority of patients fail to reach recommended iPTH values, parathyroidectomy remains a valuable tool to attain these NKF-K/DOQI recommendations for serum calcium, phosphorus and CaxPO(4) in dialysis patients with secondary hyperparathyroidism resistant to medical therapy. Parathyroidectomy was shown to be an inadequate intervention for achieving KDIGO recommendations.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 26 条
[1]   Achieving K/DOQI laboratory target values for bone and mineral metabolism:: An uphill battle [J].
Al Aly, Z ;
González, EA ;
Martin, KJ ;
Gellens, ME .
AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (04) :422-426
[2]   Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease:: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units [J].
Arenas, M. Dolores ;
Alvarez-Ude, Fernando ;
Gil, M. Teresa ;
Soriano, Antonio ;
Egea, Juan Jose ;
Millan, Isabel ;
Amoedo, M. Luisa ;
Muray, Salome ;
Carreton, M. Antonia .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (06) :1663-1668
[3]   K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients [J].
Barreto, F. C. ;
Barreto, D. V. ;
Moyses, R. M. A. ;
Neves, K. R. ;
Canziani, M. E. F. ;
Draibe, S. A. ;
Jorgetti, V. ;
Carvalho, A. B. .
KIDNEY INTERNATIONAL, 2008, 73 (06) :771-777
[4]   Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis [J].
Block, GA ;
Martin, KJ ;
de Francisco, ALM ;
Turner, SA ;
Avram, MM ;
Suranyi, MG ;
Hercz, G ;
Cunningham, J ;
Abu-Alfa, AK ;
Messa, P ;
Coyne, DW ;
Locatelli, F ;
Cohen, RM ;
Evenepoel, P ;
Moe, SM ;
Fournier, A ;
Braun, J ;
McCary, LC ;
Zani, VJ ;
Olson, KA ;
Drüeke, TB ;
Goodman, WG .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1516-1525
[5]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[6]   Parathyroidectomy in chronic renal failure: Short- and long-term results on parathyroid function, blood pressure and anemia [J].
Coen, G ;
Calabria, S ;
Bellinghieri, G ;
Pecchini, F ;
Conte, F ;
Chiappini, MG ;
Ferrannini, M ;
Lagona, C ;
Mallamace, A ;
Manni, M ;
DiLuca, M ;
Sardella, D ;
Taggi, F .
NEPHRON, 2001, 88 (02) :149-155
[7]   Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism [J].
Costa-Hong, Valeria ;
Jorgetti, Vanda ;
Gowdak, Luis Henrique W. ;
Moyses, Rosa Maria A. ;
Krieger, Eduardo M. ;
De Lima, Jose Jayme G. .
SURGERY, 2007, 142 (05) :699-703
[8]   Consistent control of mineral and bone disorder in incident hemodialysis patients [J].
Danese, Mark D. ;
Belozeroff, Vasily ;
Smirnakis, Karen ;
Rothman, Kenneth J. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (05) :1423-1429
[9]   Association of Relatively Low Serum Parathyroid Hormone With Malnutrition-Inflammation Complex and Survival in Maintenance Hemodialysis Patients [J].
Dukkipati, Ramanath ;
Kovesdy, Csaba P. ;
Colman, Sara ;
Budoff, Matthew J. ;
Nissenson, Allen R. ;
Sprague, Stuart M. ;
Kopple, Joel D. ;
Kalantar-Zadeh, Kamyar .
JOURNAL OF RENAL NUTRITION, 2010, 20 (04) :243-254
[10]   On the evolving nature of understanding dialysis-related disorders [J].
Eknoyan, G ;
Lindberg, JS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :S1-S3